Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Patel, Ahmedabad

Bhavesh Patel, Ahmedabad IN

Patent application numberDescriptionPublished
20090275647TAXANE DERIVATIVE COMPOSITION - A stable, absolutely ethanol free composition of docetaxel that prevents alcoholic intoxication or anaphylactic shock. The composition can be in the form of a stable injectable composition that includes a taxane derivative, wherein the composition includes a mixture of docetaxel, one or more stabilizer, one or more surfactant, or more co-solvent and water for injection wherein the composition is absolutely free of ethanol.11-05-2009

Bhavesh Vallabhabhai Patel, Ahmedabad IN

Patent application numberDescriptionPublished
20100248376IN-VITRO METHOD FOR TESTING BIOEQUIVALENCE OF IRON-SUCROSE FORMULATION - The present disclosure relates to an in vitro method for measuring the T09-30-2010
20100267824STABLE OXALIPLATIN COMPOSITION FOR PARENTERAL ADMINISTRATION - The present invention relates to a stable parenteral composition of oxaliplatin having pH range in between 3 to 4.5, which comprises of a solution of oxaliplatin in water wherein the said pH is attained by sparging of carbon dioxide in the composition. Further, a method for the preparation of oxaliplatin composition of the present invention is also disclosed.10-21-2010

Dhimant Jasubhai Patel, Ahmedabad IN

Patent application numberDescriptionPublished
20100190999PROCESS FOR THE PREPARATION OF AMORPHOUS ATORVASTATIN CALCIUM - The present invention also provides the amorphous form of hemi-calcium salt of atorvastatin with high purity and processes for preparation thereof.07-29-2010

Hiren Patel, Ahmedabad IN

Patent application numberDescriptionPublished
20100075933INJECTABLE COMPOSITIONS OF VITAMIN D COMPOUNDS - Pharmaceutical injectable compositions comprising at least one vitamin D compound as an active agent, processes for preparing such compositions, and methods of using such compositions.03-25-2010

Jayantibhai Prabhuram Patel, Ahmedabad IN

Patent application numberDescriptionPublished
20100327597 SYSTEM FOR GENERATING POWER USING FLOW OF WATER - Disclosed is a system for generating electrical power using flowing water in canals, rivers and the like water streams. The system comprising: plurality of circular structures, each having a bore at the center and plurality of elongated arms being fixed on the outer periphery of said structure; plurality of blades being fitted on said plurality of elongated arms; a rotating shaft for rotatably accommodating in space apart relationship said circular structures over outer body of said shaft through said bore; an electrical generator for converting the mechanical energy generated by rotation of said shaft into electrical energy to produce electrical power; and a transmission device for transmitting the mechanical energy generated by rotation of said shaft from shaft to said electrical generator; wherein said circular structures along with blades are kept across the flow of water, the blades of said structure get rotation due to force of flowing water and generate energy which rotates said shaft which in turn generate mechanical energy and finally said mechanical energy is transmitted to electrical generator through transmission device for generating electrical power.12-30-2010

Jitendra Patel, Ahmedabad IN

Patent application numberDescriptionPublished
20120093882STABLE PHARMACEUTICAL COMPOSITIONS OF DICLOFENAC - The present invention discloses a stable pharmaceutical composition of diclofenac or salts thereof comprising nano size droplets of diclofenac or salts thereof, wherein the composition exhibits a significant difference in one or both of the rate and extent of absorption of diclofenac or salts thereof as compared to formulation of diclofenac marketed under the trade name Voveran®04-19-2012

Kalpesh Mahendrabhai Patel, Ahmedabad IN

Patent application numberDescriptionPublished
20110282094PROCESS FOR PREPARATION OF PHENOLIC MONOESTERS OF HYDROXYMETHYL PHENOLS - A process for the preparation of phenolic monoesters of 2-(3-diisopropylamino-1-phenylpropyl)-4-(hydroxymethyl)phenol by converting (±)6-halo-4-phenylchroman-2-one to (±)4-halo-2-(3-hydroxy-1-phenylpropyl)phenol. The two hydroxyl groups are protected and the protected compound is reacted with diisopropylamine to give (±)[3-(2-benzyloxy-5-halophenyl)-3-phenylpropyl]diisopropylamine. The halo substituent on the benzene ring is converted to corresponding benzyl alcohol and then the protection is removed to give racemic 5-HMT. Racemic 5-HMT is converted R enantiomer and then it is esterified.11-17-2011

Keyur Patel, Ahmedabad IN

Patent application numberDescriptionPublished
20100248376IN-VITRO METHOD FOR TESTING BIOEQUIVALENCE OF IRON-SUCROSE FORMULATION - The present disclosure relates to an in vitro method for measuring the T09-30-2010

Manish Popatlal Patel, Ahmedabad IN

Patent application numberDescriptionPublished
20090281323PROCESS FOR THE MANUFACTURE OF MONTELUKAST SODIUM - Process for the manufacture of 1-[[[(1R)-1-[3-[(1E)-2-(7-chloro-2-quinolinyl)ethenyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]thio]methyl]cyclopropane acetic acid, sodium salt [montelukast sodium (I)] consisting of: i. Converting methyl 1-(mercaptomethyl)-cyclopropaneacetate to a metal salt (X) using a metal hydroxide, ii. Subjecting the metal salt (X) to monometallation to provide a dimetallide (XI). iii. Converting a diol of formula (II) to a mesylate of formula (III) and reacting (III) in situ with (XI) affordin the metal salt of 1-[[[(1R)-1-[3-[(1E)-2-(7-chloro-2-quinolinyl)ethenyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]thio]methyl]cyclopropane acetic acid. iv. Reacting the metal salt in-situ with a base and purifying to afford an amine salt (XII). v. Treating (XII) with a sodium base and precipitating out montelukast sodium (I).11-12-2009

Nilamkumari Somalal Patel, Ahmedabad IN

Patent application numberDescriptionPublished
20120027849STABLE PHARMACEUTICAL COMPOSITION FOR ATHEROSCLEROSIS - The present invention relates to a stable solid oral pharmaceutical multi-component composition comprising combination of blood pressure lowering drugs with lipid lowering agent/s and optionally a platelet aggregation inhibitor in a single dosage form. The blood pressure lowering agents are selected from β-adrenergic receptor blocking agent, ACE inhibitor and diuretic. The lipid lowering agent is selected from HMG Co-enzyme-A reductase inhibitor. The pharmaceutical composition made as per present invention a) overcomes any drug-drug interactions, b) exhibits pharmacokinetic and pharmacodynamic profile of individual therapeutic agent, c) has minimal side effects. The invention provides multi-component composition (MCC) to increase adherences to therapy. The MCC as per present invention provides compositions that maintain activity of all active ingredients without significant increase in adverse event profile. The present invention further relates to a method of preparing the said pharmaceutical composition.02-02-2012

Pankaí R. Patel, Ahmedabad IN

Patent application numberDescriptionPublished
20120108496SHORT-CHAIN PEPTIDES AS PARATHYROID HORMONE (PTH) RECEPTOR AGONIST - The present invention provides novel short-chain peptides, which primarily act as parathyroid hormone (PTH/PTH-1) receptor agonist. These short-chain peptides exhibit increased stability to proteolytic cleavage. Most of short-chain peptides were found to be stable in rat plasma up to 24 hours (in vitro), showed increased stability against GIT enzymes such as pepsin and acidic stomach pH and also against liver microsomes (in vitro). Due to increased metabolic stability, other than parenteral route of administration, some of the short-chain peptides can also be delivered by oral routes of administration, for the treatment/prevention of hypoparathyroidism and diseases characterized by bone mass reduction, such as osteoporosis, postmenopausal osteoporosis and for stimulating bone repair. A-Z05-03-2012

Parixit Amrutbhai Patel, Ahmedabad IN

Patent application numberDescriptionPublished
20120126036NON PRESSURE COMPENSATED DRIP IRRIGATION EMITTER WITH MULTIFLOW FACILITY - Described is a non pressure compensated drip emitter with multiflow facility, the drip emitter being placed inside a pipe of a drip irrigation system, the drip emitter comprising: a housing; a filter system being fitted at each inlet to ensure pure supply of water inside the emitter; three pools of water from only one of which water get discharged out of emitter and from emitter to the land to be irrigated, the third pool in the middle; a labyrinth in fluid communication with each pool and the filter system, the labyrinth comprises zigzag water paths; wherein the labyrinth connects middle pool with remaining two pools through the zigzag water path in such a way that even in case of partial clogging of the zigzag water path, the remaining partial zigzag water path remain active and ensure the discharge of water at a selected flow rate from the emitter.05-24-2012

Prashant Yogesh Patel, Ahmedabad IN

Patent application numberDescriptionPublished
20110020440STABLE SOLUTIONS OF SPARINGLY SOLUBLE ACTIVES - The present invention relates to a stable pharmaceutical composition comprising soft gelatin capsules containing at least one sparingly soluble active drug (singly or in combination with sparingly soluble and/or soluble drugs) and a solvent system, wherein the solvent system comprises of solvent, co-solvent, solubilizer(s), surfactant, aqueous solution of alkali and crystal growth inhibitor. The present invention further relates to process for preparing a stable pharmaceutical composition of sparingly soluble active drug(s) in soft gelatin capsules.01-27-2011

Sanjay Maganbhai Patel, Ahmedabad JP

Patent application numberDescriptionPublished
20110177137NOVEL DOSAGE FORM OF PALIPERIDONE AND PROCESS FOR PREPARING THE SAME - The present invention relates to an extended release composition of paliperidone for oral administration comprising paliperidone and at least one matrixing agent. The said extended release composition maintains desired therapeutic drug effect over a prolonged period of time and thereby reduces the side effects resulting due to excess drug blood plasma concentration. Further, the invention also relates to process for the preparation of an extended release oral composition of paliperidone.07-21-2011

Vishnu Jagdishbhai Patel, Ahmedabad IN

Patent application numberDescriptionPublished
20100304321FIVE SEGMENT ORTHODONTIC ARCH WIRE AND ORTHODONTIC APPARATUS MADE THEREOF - The present invention relates to an arch wire that is used during orthodontic treatment. In accordance to the present invention a five segment orthodontic arch wire to provide a track for movement of teeth for correcting misalignment of teeth, said arch wire generally having ‘U’ shape and having same longitudinal axis through out the length, said arch wire characterized by: first segment having rectangular cross section and being provided for the posterior, 2nd premolar and molar region in left side of the jaw; second segment having rectangular cross section with rounded off corners, said second segment is followed by said first segment and provided for the canine and first premolar region in left side of the jaw; third segment having rectangular cross section, said third segment is followed by said second segment and provided for the anterior, incisor region; fourth segment having rectangular cross section with rounded off corners, said fourth segment is followed by said third segment and provided for the canine and 1st premolar region in right side of the jaw; and fifth segment having rectangular cross section, said fifth segment is followed by said fourth segment and provided for the posterior, 2nd premolar and molar region in right side of the jaw, wherein said arch wire is single piece and continuous in construction. Also an orthodontic apparatus comprising a five segment orthodontic arch wire in accordance with the present invention along with slotted bracket is also provided.12-02-2010